Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksElementis Regulatory News (ELM)

Share Price Information for Elementis (ELM)

Share Price is delayed by 15 minutes
Get Live Data
156.40    2.40 (1.56%)
Bid:
156.40
Ask:
156.60
Spread: 0.20 (0.128%)
Market Cap: £893.79m
ELM Live PriceLast checked at - London Stock Exchange

Intraday Elementis Share Chart

Trading update

14 Jan 2021 07:00

RNS Number : 6200L
Elementis PLC
14 January 2021
 

Elementis plc

Trading Update

Sequential revenue improvement, FY 20 adjusted operating profit $81-83m

Significant reduction in net debt, anticipated to be under $415m

Elementis plc ("Elementis" or the "Group"), a global specialty chemicals company, today issues a trading update for the three months ended 31 December 2020.

Fourth quarter business performance

 

Fourth quarter revenue is expected to be ahead of the third quarter driven by improved volumes and largely stable pricing. Overall performance in the quarter is anticipated to be in line with management expectations, helped by tight cost management and supply chain efficiencies. As a result, adjusted operating profit for 2020 is expected to be $81-83m.

· Coatings has continued to perform well in Q4, albeit at lower levels than the prior year period, and remains on track to deliver improved operating margins versus the prior year.

 

· Personal Care sales remain materially lower than the prior year period in both Cosmetics and AP Actives, due to the continuation of COVID-19 related social and travel restrictions that have reduced consumption. Q4 performance is anticipated to be in line with Q3 levels. 

 

· Talc volumes continued to recover, driven by improved long-life plastic demand for automotive applications and resilience in coatings. As a result, Q4 revenue is expected to be ahead of the prior year period.

· Chromium demand has sequentially improved, driven by increased demand for industrial applications such as leather tanning and metal plating. As a result, Q4 revenue is anticipated to be broadly in line with the prior year period.

 

· Energy continues to experience very weak market conditions with rig counts and activity levels remaining subdued.

 

In the fourth quarter we have continued to deliver against our Innovation, Growth and Efficiency strategy. For full year 2020 we launched 12 new products, captured over $30m of new business and delivered $15m of in year cost savings.

For 2021, whilst our new business and innovation pipelines are encouraging, we continue to face temporary demand challenges from COVID-19, particularly in Personal Care where we expect performance will recover when social and travel restrictions are lifted. As a result of the recently announced closure of our plant in Charleston, West Virginia, we have made further progress underpinning $10m of supply chain cost efficiencies, and our new AP Actives plant in India remains on track for mid-2021 start up.

Liquidity and balance sheet

 

As result of tight working capital management and disciplined capital expenditure, net debt* at the end of 2020 is anticipated to be under $415m, representing a significant reduction from $454m at the start of the year.

 

Elementis has a proven cash generative business model, with average operating cash conversion above 90% over the last 3 years, and the Group continues to operate with ample liquidity, with over $300m immediately available through committed lending facilities.

 

 

 

Enquiries

Elementis plc

James Curran, Investor Relations Tel: 020 7067 2994

 

Tulchan

Martin Robinson Tel: 020 7353 4200

David Allchurch

 

* Excluding IFRS 16 impact

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTFZGMMRFGGMZM
Date   Source Headline
27th Jan 20149:00 amPRNAppointment of Chairman-Designate
22nd Jan 201411:00 amPRNAdditional Listing
31st Dec 201311:00 amRNSTotal Voting Rights
29th Nov 201311:00 amRNSTotal Voting Rights
31st Oct 201311:00 amRNSTotal Voting Rights
25th Oct 20137:00 amRNSInterim Management Statement
16th Oct 20131:00 pmRNSAdditional Listing
1st Oct 20139:00 amRNSDirectorate Change
30th Sep 201311:00 amRNSTotal Voting Rights
6th Sep 20131:00 pmRNSDirector/PDMR Shareholding
2nd Sep 20134:00 pmRNSBlocklisting Interim Review
30th Aug 20131:00 pmRNSTotal Voting Rights
28th Aug 201311:00 amRNSDirector/PDMR Shareholding
23rd Aug 20134:30 pmRNSHolding(s) in Company
2nd Aug 20134:00 pmRNSHolding(s) in Company
31st Jul 20134:01 pmRNSHolding(s) in Company
31st Jul 20134:00 pmRNSDirector/PDMR Shareholding
31st Jul 20131:00 pmRNSTotal Voting Rights
30th Jul 20137:00 amRNSInterim Results
22nd Jul 20137:00 amRNSDirectorate Change
3rd Jul 201311:00 amRNSHolding(s) in Company
28th Jun 201312:42 pmRNSTotal Voting Rights
3rd Jun 201312:00 pmRNSTotal Voting Rights
22nd May 201311:00 amRNSAdditional Listing
7th May 20131:00 pmRNSDirector/PDMR Shareholding
7th May 20137:00 amRNSDirectorate Change
30th Apr 201311:00 amRNSTotal Voting Rights
25th Apr 20133:12 pmRNSResult of AGM
25th Apr 20137:00 amRNSAGM Statement
12th Apr 201311:00 amRNSDirector/PDMR Shareholding
3rd Apr 20134:10 pmRNSDirector/PDMR Shareholding
28th Mar 201311:30 amRNSTotal Voting Rights
25th Mar 201311:00 amRNSHolding(s) in Company
21st Mar 20139:30 amRNS2012 Annual Financial Report & Notice of 2013 AGM
6th Mar 201311:00 amRNSHolding(s) in Company
6th Mar 201311:00 amRNSAdditional Listing
6th Mar 201311:00 amRNSHolding(s) in Company
1st Mar 201311:00 amRNSBlocklisting Interim Review
28th Feb 201311:00 amRNSTotal Voting Rights
26th Feb 20137:00 amRNSFinal Results
25th Feb 201311:00 amRNSHolding(s) in Company
20th Feb 20137:00 amRNSAcquisition
8th Feb 201311:00 amRNSDirector Declaration
1st Feb 201311:00 amRNSDirector/PDMR Shareholding
31st Jan 201311:00 amRNSTotal Voting Rights
24th Jan 201311:00 amRNSHolding(s) in Company
24th Jan 201311:00 amRNSHolding(s) in Company
17th Jan 201311:00 amRNSDirector/PDMR Shareholding
2nd Jan 201311:00 amRNSTotal Voting Rights
30th Nov 201211:00 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.